Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Litton

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Cancer|May 29, 2015
Reply to BRCA2-associated pancreatic cancer and current screening guidelinesJennifer K Litton, Jeffrey H Lee, Banu K Arun
Expert Opinion on Pharmacotherapy|July 26, 2021
Development of the PARP inhibitor talazoparib for the treatment of advanced <i>BRCA1</i> and <i>BRCA2</i> mutated breast cancerEvthokia A Hobbs, Jennifer K Litton, Timothy A Yap
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Molecular Testing in Breast CancerJennifer K Litton, Harold J Burstein, Nicholas C Turner
Women'S Health (London, England)|April 28, 2009
Breast cancer diagnosis during pregnancyJennifer K Litton, Richard L Theriault, Ana M Gonzalez-Angulo
Journal of Thoracic Disease|July 3, 2013
Breast cancer in the young: role of the geneticistAshley H Woodson, Jessica L Profato, Kimberly I Muse, et al.
Journal of the American Dental Association (1939)|February 15, 2018
Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancerMark S Chambers, Hope S Rugo, Jennifer K Litton, et al.
JCO Precision Oncology|August 29, 2024
Pharmacodynamic Activity of [<sup>18</sup>F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With <i>BRCA1/2</i>-Mutated Breast Cancer Receiving TalazoparibLilie L Lin, Franklin Wong, Ruitao Lin, et al.
Breast Cancer Research and Treatment|December 27, 2015
Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
Breast Cancer Research and Treatment|July 29, 2016
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
Pediatric Blood & Cancer|August 30, 2018
Breast cancer in adolescents and young adultsRebecca H Johnson, Carey K Anders, Jennifer K Litton, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Cancer|May 29, 2015
Reply to BRCA2-associated pancreatic cancer and current screening guidelinesJennifer K Litton, Jeffrey H Lee, Banu K Arun
Expert Opinion on Pharmacotherapy|July 26, 2021
Development of the PARP inhibitor talazoparib for the treatment of advanced <i>BRCA1</i> and <i>BRCA2</i> mutated breast cancerEvthokia A Hobbs, Jennifer K Litton, Timothy A Yap
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Molecular Testing in Breast CancerJennifer K Litton, Harold J Burstein, Nicholas C Turner
Women'S Health (London, England)|April 28, 2009
Breast cancer diagnosis during pregnancyJennifer K Litton, Richard L Theriault, Ana M Gonzalez-Angulo
Journal of Thoracic Disease|July 3, 2013
Breast cancer in the young: role of the geneticistAshley H Woodson, Jessica L Profato, Kimberly I Muse, et al.
Journal of the American Dental Association (1939)|February 15, 2018
Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancerMark S Chambers, Hope S Rugo, Jennifer K Litton, et al.
JCO Precision Oncology|August 29, 2024
Pharmacodynamic Activity of [<sup>18</sup>F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With <i>BRCA1/2</i>-Mutated Breast Cancer Receiving TalazoparibLilie L Lin, Franklin Wong, Ruitao Lin, et al.
Breast Cancer Research and Treatment|December 27, 2015
Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
Breast Cancer Research and Treatment|July 29, 2016
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
Pediatric Blood & Cancer|August 30, 2018
Breast cancer in adolescents and young adultsRebecca H Johnson, Carey K Anders, Jennifer K Litton, et al.
Pageof 17